Medicine & Life Sciences
Malaria
100%
Vaccines
81%
Malaria Vaccines
80%
Plasmodium falciparum
56%
RTS,S-AS01 vaccine
50%
Infections
38%
saponin QA-21V1
36%
Antibodies
32%
SARS Virus
31%
Antibody Formation
30%
Ebola Vaccines
30%
Falciparum Malaria
28%
Vaccination
28%
Ebolavirus
27%
Antigens
22%
Epitopes
19%
Democratic Republic of the Congo
19%
Proteins
18%
Safety
17%
Vaccine Immunogenicity
17%
Placebos
16%
Neutralizing Antibodies
15%
Ebola Hemorrhagic Fever
15%
GS-5734
15%
Immunoglobulin G
13%
Liposomes
13%
Enzyme-Linked Immunosorbent Assay
13%
Quillaja
13%
Plasmodium vivax
13%
Monoclonal Antibodies
12%
Sporozoites
12%
Immunization
12%
Military Personnel
11%
Coronavirus
11%
Culicidae
11%
Smallpox Vaccine
11%
monophosphoryl lipid A
10%
Confidence Intervals
10%
Mupirocin
10%
Anopheles
9%
Bacillus anthracis
9%
Vivax Malaria
9%
Bacteremia
9%
Immunoglobulin M
9%
Bites and Stings
9%
Vesicular Stomatitis
9%
Luminescence
8%
Cholera
8%
Vibrio cholerae
8%
Blood Culture
8%
Agriculture & Biology
Plasmodium falciparum
44%
malaria
36%
malaria vaccines
29%
immunogenicity
25%
vaccines
18%
infection
16%
antigens
14%
antibodies
13%
antibody formation
13%
falciparum malaria
12%
mosquito bites
12%
dosage
11%
Plasmodium vivax
10%
secondary immunization
10%
Bacillus anthracis
9%
safety assessment
9%
adjuvants
8%
immune response
8%
immunoassays
7%
phagocytosis
7%
monoclonal antibodies
7%
proteins
7%
epitopes
6%
enzyme-linked immunosorbent assay
6%
quantitative polymerase chain reaction
5%